Contact Information: INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848 MEDIA CONTACT: Janice Meraglia 631-444-6293 fax 631-444-8848 FCMN Contact: Web site: http://www.adnas.com
Applied DNA Sciences Successfully Embeds SigNature DNA Into Intaglio Inks for Secure Documents
| Source: Applied DNA Sciences
STONY BROOK, NY--(Marketwire - April 7, 2009) - Applied DNA Sciences, Inc. (OTCBB : APDN ), a
provider of DNA-based security solutions, announced today that it has
successfully embedded its proprietary SigNature® DNA into intaglio inks,
adding to its proven portfolio of DNA security inks. With a typical
organization experiencing more than one fraud attempt in every 1,000
documents issued (Standard Register), APDN can be a valued ally in the
battle against counterfeiting.
As advancements in technology make it easier to commit fraud, the FBI
recently described counterfeiting as "the crime of the century." Each year,
U.S. companies lose more than $650 billion to fraud, with counterfeiting
and document fraud constituting more than two-thirds of that figure
(Association of Certified Fraud Examiners). Intaglio printing is an overt
security technology available to provide anti-counterfeiting protection for
documents that have dollar or data value, such as currency, stocks, bonds
and certificates of authenticity.
When layered into intaglio and other security inks, SigNature DNA is the
premier solution available for absolute protection against counterfeiting.
DNA can be neither copied nor scanned and provides forensic evidence of
authenticity. Lastly, because APDN uses botanical DNA, this becomes a
scalable and affordable green solution. SigNature DNA can also be used
with fluorescing inks, 2D barcodes and holograms.
About Applied DNA Sciences, Inc.
Applied DNA Sciences markets and sells DNA security solutions to protect
products, brands, and intellectual property from counterfeiting and
diversion. Its patented technologies sold under SigNature DNA use DNA from
plants to mark and authenticate products in a unique manner that
essentially cannot be copied. Applied DNA also provides BioMaterial
GenoTyping™ services by using genomic DNA present in natural materials
to identify the original source of DNA present in finished products. Both
platform technologies protect brands and products in a wide range of
industries and provide a forensic chain of evidence to enable enforcement
agencies to prosecute perpetrators. To learn more, go to www.adnas.com.
APDN's common stock is listed on the Over-The-Counter Bulletin Board under
the symbol "APDN."
The statements made by APDN may be forward-looking in nature and are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe APDN's future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of which
are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial
resources, limited market acceptance, market competition and various other
factors detailed from time to time in APDN's SEC reports and filings,
including our Annual Report on Form 10-K, filed on December 16, 2008 and
our subsequent quarterly reports on Form 10-Q. APDN undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to reflect the
occurrence of unanticipated events.